10003 PRO Current Products (10003)
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
This post-marketing investigation will evaluate the functional knee performance of Subjects who have undergone primary total knee arthroplasty (TKA). Data from Subjects who receive one of four contemporary knee configurations from different manufacturers will be pooled to establish a contemporary dataset.
The primary objective of this study is to evaluate the functional performance as measured by the activities of daily living (ADL) sub-score of the Knee Osteoarthritis Outcomes Score (KOOS) patient-reported outcome (PRO) questionnaire of primary TKA at minimum one year post-operation. This will be carried out for all four implant configurations. The final endpoint is a 2-year evaluation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The study is designed as a prospective, single arm stratified, multi-center investigation.
Approximately 20 study sites, worldwide, will enroll 840 patients (840 knees). Each study site is expected to enroll approximately 42 patients (42 knees). Cohort reallocation is permitted. There will be no control group. Eight hundred forty (840) Subjects will be stratified into 4 subgroups of 210: fixed bearing cruciate retaining (FB CR), fixed bearing posterior stabilized (FB PS), rotating platform cruciate retaining (RP CR), and rotating platform posterior stabilized (RP PS).
Treatment assignment in this study is not randomized. Each site will only enroll patients in one of the four knee configuration sub-groups most commonly used as their standard of care.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
New South Wales
-
Hornsby, New South Wales, Australie, 2077
- Hornsby Ku-Ring-Gai Hospital
-
-
South Australia
-
Adelaide, South Australia, Australie, 5000
- Wakefield Orthopedic Clinic
-
-
Western Australia
-
Crawley, Western Australia, Australie, 6009
- Freemantle Hospital
-
Perth, Western Australia, Australie, 6000
- Royal Perth Hospital
-
-
-
-
-
Auckland, Nouvelle-Zélande
- Ascot Hospital
-
-
-
-
-
Harlow, Royaume-Uni, CM20 1QX
- Princess Alexandra Hospital
-
Llandough, Royaume-Uni, CF64 2XX
- University Hospital Llandough
-
Middlesborough, Royaume-Uni, TS4 3BW
- James Cook University Hospital
-
York, Royaume-Uni, YO30 5RA
- Clifton Park NHS Treatment Centre
-
-
Fife
-
Dunfermline, Fife, Royaume-Uni, KY12 OSU
- Queen Margaret Hospital
-
-
Surrey
-
Guildford, Surrey, Royaume-Uni, GU2 7XX
- The Royal Surrey County Hospital
-
-
-
-
California
-
Orange, California, États-Unis, 92868
- Orthopaedic Specialty Institute
-
San Diego, California, États-Unis, 92103
- UCSD Medical Center
-
-
Colorado
-
Fort Collins, Colorado, États-Unis, 80525
- Orthopaedic Center of the Rockies
-
-
Florida
-
Jacksonville, Florida, États-Unis, 32205
- Heekin Institute for Orthopedic Research
-
-
Kentucky
-
Louisville, Kentucky, États-Unis, 40215
- The Arthroplasty Foundation
-
-
Louisiana
-
New Orleans, Louisiana, États-Unis, 70112
- Tulane University Hospital and Clinic
-
-
Nevada
-
Las Vegas, Nevada, États-Unis, 89128
- Hip and Knee Research of Nevada
-
-
New Hampshire
-
Lebanon, New Hampshire, États-Unis, 03756
- Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
-
-
Ohio
-
Columbus, Ohio, États-Unis, 43213
- Cardinal Orthopaedic Institute
-
-
Virginia
-
Alexandria, Virginia, États-Unis, 22307-9804
- Anderson Orthopaedic Research Institute
-
-
Washington
-
Seattle, Washington, États-Unis, 98122-5330
- Swedish Orthopedic Institute
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Subject is male or female and between the ages of 22 and 80 years, inclusive.
- Subject was diagnosed with NIDJD.
- Subject is a suitable candidate for cemented primary TKA using the devices described in this CIP with either a resurfaced or non-resurfaced patellae.
- Subject's TKA device was one of the total knee prostheses described under Interventions.
- Subject is currently not bedridden.
- Subject has given voluntary, written informed consent to participate in this clinical investigation, is willing and able to perform all study procedures and follow-up visits and has authorized the transfer of his/her information to DePuy.
- Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures.
- Subject must be comfortable with speaking, reading, and understanding questions and providing responses in English.
- The devices specified in this CIP were implanted.
Exclusion Criteria:
- The Subject is a woman who is pregnant or lactating.
- Contralateral knee has already been enrolled in this study.
- Subject had a contralateral amputation.
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
- Subject is currently experiencing radicular pain from the spine.
- Subject has participated in an IDE/IND clinical investigation with an investigational product in the last three months.
- Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
- Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to complete patient reported questionnaires.
- Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication.
- Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease).
- Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.).
- Subject is not comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the CIP.
- Subject has a medical condition with less than 2 years of life expectancy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
CR FB
Subjects receiving a Cruciate Retaining Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS FB
Subjects Receiving a Posterior Stabilized Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
CR RP
Subjects receiving a Cruciate Retaining Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS RP
Subjects receiving a Posterior Stabilized Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Knee injury and Osteoarthritis Outcome Score (KOOS) activities of daily living (ADL) sub-score
Délai: up to one year
|
The primary endpoint will be measuerd before surgery and out to a minimum of 1 year after surgery.
The KOOS is a patient self-administered questionnaire that consists of 42 questions.
The KOOS consists of 5 subscales; pain, other symptoms, activities of daily living (ADL), sport and recreational function and knee-related quality of life.
Each question has 5 Likert-like response options.
A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
|
up to one year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Evaluate the psychometric properties of PKIP
Délai: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
The Pre and Post-Surgical Patient's Knee Implant Performance (PKIP) questionnaire is a patient self-administered questionnaire that consists of 25 questions relating to the patient's awareness of their knee.
Questions include the patient's self-confidence about the current status of their knee performance, stability, and overall satisfaction.
Each question has a 5, 6 or 10 Likert- like response option.
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
Evaluate the longitudinal functional performance of primary TKA
Délai: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate Incidence of Anterior Knee Pain
Délai: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate incidence of asymptomatic and symptomatic crepitus
Délai: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate patients functional performance for PS knees, CR knees, FB knees, and RP knees
Délai: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Ahmad S. Ismail, MS, CCRP, DePuy Orthopaedics
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 10003
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .